List of JWH cannabinoids
JWH cannabinoids are a series of synthetic cannabinoids that were developed by John W. Huffman, an organic chemist at Clemson University. They are often used in scientific research and have also been sold as designer drugs. The JWH series is named after Huffman's initials.
History[edit | edit source]
The JWH series was first synthesized in the 1990s by Huffman and his team in an effort to create a new class of cannabinoid receptor agonists for use in scientific research. The compounds were initially developed to aid in the study of the endocannabinoid system, but have since been used in a variety of other research contexts.
Structure and Function[edit | edit source]
JWH cannabinoids are structurally diverse, but all share a common feature: they are able to bind to and activate the cannabinoid receptors in the brain and other tissues. This makes them useful tools for studying the function of these receptors, as well as for exploring potential therapeutic applications of cannabinoids.
List of JWH Cannabinoids[edit | edit source]
Some of the most well-known JWH cannabinoids include:
- JWH-018: One of the first and most infamous of the JWH cannabinoids, JWH-018 is a potent synthetic cannabinoid that has been associated with numerous cases of overdose and adverse reactions.
- JWH-073: A less potent analogue of JWH-018, JWH-073 is often used in scientific research due to its more manageable effects.
- JWH-133: A selective CB2 receptor agonist, JWH-133 is often used in research into potential therapeutic applications of cannabinoids.
- JWH-200: A potent cannabinoid receptor agonist, JWH-200 has been associated with a number of adverse reactions and is often used as a reference compound in research into the toxicology of synthetic cannabinoids.
Legal Status[edit | edit source]
Due to their potential for abuse and the health risks associated with their use, many JWH cannabinoids are controlled substances in many countries. In the United States, for example, several JWH cannabinoids are classified as Schedule I controlled substances under the Controlled Substances Act.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
